Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Dermatology | Family Medicine
Disease Category: Rosacea
Location: United States, CO

Clinical Trial Details


Research Study Summary

Now enrolling for a clinical research study for the treatment of Rosacea.


Do you have moderate to severe rocacea? Horizons Clinical Research Center, LLC is testing an investigational medication to determine how well it treats rosacea.

Qualified participants will receive all study related clinic visits, lab assessments, medical exams, and study medication at no cost throughout the study, plus compensation for time and travel.

Patient Inclusion Criteria:

  • If you are at least 18 years of age, are experiencing moderate to severe rosacea (8-50 inflamed lesions on the face, moderate redness and some visibly dilated blood vessels.) then you may qualify for this study.

Patient Exclusion Criteria:

  • You must not have excessive facial hair that would hinder assessment and if female you must not be pregnant, nursing or planning to become pregnant in the next three months.

To Learn more

CW ID: 178417
Date Last Changed: July 19, 2013

Clinical Trial Snapshot

Both Male and Female
18 and up
Overall Status
Facility Type


Isabel Arnold, Director
Horizons Clinical Research Center, LLC
4495 Hale Parkway, Suite 101
Denver, CO 80220
Phone: 303-399-4067

View Map

Research Center Information:

Horizons Clinical Research Center, LLC

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.